IO Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IO Biotech and buy or sell other stocks, ETFs, and their options commission-free!About IOBTQ
IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms.
CEOMai-Britt Zocca, PhD
CEOMai-Britt Zocca, PhD
Employees80
Employees80
HeadquartersCopenhagen, North Denmark
HeadquartersCopenhagen, North Denmark
Founded2014
Founded2014
Employees80
Employees80
IOBTQ Key Statistics
Market cap7.19K
Market cap7.19K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume33.39K
Average volume33.39K
High today$0.0001
High today$0.0001
Low today$0.0001
Low today$0.0001
Open price$0.0001
Open price$0.0001
Volume4.61K
Volume4.61K
52 Week high$1.67
52 Week high$1.67
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
The current IO Biotech(IOBTQ) stock price is $0.00, with a market capitalization of 7.19K.
As of 2026-09-22, IO Biotech(IOBTQ) stock has fluctuated between $0.00 and $0.00. The current price stands at $0.00, placing the stock 0.0% above today's low and 0.0% off the high.
IO Biotech(IOBTQ) shares are trading with a volume of 4.61K, against a daily average of 33.39K.
During the past year, IO Biotech(IOBTQ) stock moved between $0.00 at its lowest and $1.67 at its peak.
During the past year, IO Biotech(IOBTQ) stock moved between $0.00 at its lowest and $1.67 at its peak.
People also own
Based on the portfolios of people who own IOBTQ. This list is generated using Robinhood data, and it’s not a recommendation.